⚠️ This provider averages 711 services per working day — physically unusual for an individual practitioner
Based on 1.8M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $27.3M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 711 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 61% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $35.30 | $17.39 | 2.03x | $17.91 | $2.1M | 122.1K | 51 |
| 2015 | $47.08 | $13.27 | 3.55x | $33.81 | $1.5M | 115.6K | 58 |
| 2016 | $59.21 | $18.48 | 3.20x | $40.73 | $2.5M | 133.2K | 73 |
| 2017 | $62.17 | $19.60 | 3.17x | $42.57 | $2.5M | 130.0K | 70 |
| 2018 | $56.10 | $17.31 | 3.24x | $38.79 | $3.1M | 178.8K | 65 |
| 2019 | $48.59 | $15.85 | 3.07x | $32.74 | $3.4M | 214.9K | 66 |
| 2020 | $43.32 | $14.14 | 3.06x | $29.18 | $3.1M | 219.2K | 67 |
| 2021 | $50.99 | $15.38 | 3.32x | $35.61 | $3.4M | 219.0K | 66 |
| 2022 | $42.35 | $12.30 | 3.44x | $30.05 | $2.7M | 218.4K | 61 |
| 2023 | $45.65 | $13.13 | 3.48x | $32.52 | $3.0M | 226.3K | 47 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 127.0K | $5.2M | $41.03 | 3.08x |
| J9299 | Injection, nivolumab, 1 mg | 112.4K | $2.4M | $21.63 | 3.12x |
| J0897 | Injection, denosumab, 1 mg | 140.2K | $1.9M | $13.85 | 2.69x |
| J2505 | Injection, pegfilgrastim, 6 mg | 643 | $1.9M | $3.0K | 2.53x |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | 9.5K | $1.5M | $158.18 | 2.53x |
| J9310 | Injection, rituximab, 100 mg | 2.5K | $1.5M | $606.82 | 2.25x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 13.0K | $1.1M | $86.08 | 3.07x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 102.9K | $880.5K | $8.56 | 2.64x |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 22.1K | $822.7K | $37.16 | 2.96x |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 16.2K | $801.6K | $49.60 | 2.12x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 7.0K | $777.0K | $111.40 | 3.46x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 17.3K | $597.3K | $34.62 | 3.00x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 8.1K | $480.9K | $59.72 | 3.24x |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | 399 | $439.9K | $1.1K | 3.55x |
| J9035 | Injection, bevacizumab, 10 mg | 6.8K | $422.3K | $62.47 | 3.06x |
| J9395 | Injection, fulvestrant, 25 mg | 6.0K | $376.4K | $62.22 | 2.86x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 498.8K | $336.3K | $0.67 | 4.28x |
| J9312 | Injection, rituximab, 10 mg | 4.3K | $320.2K | $74.46 | 3.21x |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 6.1K | $291.9K | $47.85 | 3.82x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 28.9K | $260.3K | $9.01 | 3.06x |
This provider submits charges 3.17 times higher than what Medicare actually pays.
A markup ratio of 3.17x means for every $100 Medicare pays, this provider initially charges $317. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Christopher Lobo, MD | Port Charlotte, FL | $60.5M | ⚠️ Flagged |
| Maen Hussein, M.D. | Tavares, FL | $57.6M | ✓ Clear |
| Vikas Malhotra, M.D. | Spring Hill, FL | $52.8M | ✓ Clear |
| Andrew Lipman, M.D. | Naples, FL | $51.1M | ⚠️ Flagged |
| Syed Zafar, M.D. | Fort Myers, FL | $48.1M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data